We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

CHRONIC GINGIVOSTOMATITIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2020 to 2027)

Chronic Gingivostomatitis Treatment Market, by Diagnosis (Physical Examination, Microbial Culture, Biopsy, and Others), by Treatment (Non-steroidal Anti-inflammatory Drugs, Antiviral, Antibacterial, and Others), by End User (Hospitals & Clinics, Academic & Research, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In: 18 Dec, 2020
Code: CMI4308
Pages: 180
Formats: Excel and PDF
Industry: Pharmaceutical

Gingivostomatitis is a contagious mouth infection, which causes painful sores, blisters, and swelling in the tongue and uvula. It usually spreads through the saliva of an infected individual or by direct contact with a lesion or sore. Gingivostomatitis is also called as herpetic, which is caused by herpes simplex virus and is the most common cause of gingivostomatitis. Gingivostomatitis is the most common among young children, usually under 6 years old, but it may also occur in adults. Geriatric people may experience severe symptoms than adults and children.

Market Dynamics

Rising incidence of gingivostomatitis caused by herpes simplex virus (HSV) is expected to drive the chronic gingivostomatitis treatment market growth. For instance, according to the International Journal of Dentistry, an article published in October 2016, reports that over 90% of gingivostomatitis cases are caused by herpes simplex virus (HSV) type 1 and the remainder are caused by herpes simplex virus (HSV) type 2.

However, lack of identification or diagnosis of chronic gingivostomatitis are expected to hinder the market growth. For instance, according to the Journal of Dental Health Oral Disorders & Therapy, an article published in 2017, states that chronic gingivostomatitis may be asymptomatic in some instances, may be unnoticed in some instances, and sometimes get misdiagnosed with other chronic mouth ulcers.

Key features of the study:

This report provides in-depth analysis of the global chronic gingivostomatitis treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chronic gingivostomatitis treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study are Pfizer Inc., Taj Pharmaceutical limited, Ciron pharma, Johnson & Johnson, GlaxoSmithKline PLC, Merck & CO., Inc., Novartis AG, F. Hoffman La Roche AG, Eli Lily and Company, and AstraZeneca Plc. among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global chronic gingivostomatitis treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic gingivostomatitis treatment market

Detailed Segmentation:

Global Chronic Gingivostomatitis Treatment Market, By Diagnosis:
- Physical Examination
- Microbial Culture
- Biopsy
- Others
Global Chronic Gingivostomatitis Treatment Market, By Treatment:
- Non-steroidal Anti-inflammatory Drugs
- Antiviral
- Antibacterial
- Others
Global Chronic Gingivostomatitis Treatment Market, By End User:
- Hospitals & Clinics
- Academic & Research
- Others
Global Chronic Gingivostomatitis Treatment Market, By Region:
- North America
  - By Diagnosis:
    - Physical Examination
    - Microbial Culture
    - Biopsy
    - Others
  - By Treatment:
    - Non-steroidal Anti-inflammatory Drugs
    - Antiviral
    - Antibacterial
    - Others
  - By End User:
    - Hospitals & Clinics
    - Academic & Research
    - Others
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Diagnosis:
    - Physical Examination
    - Microbial Culture
    - Biopsy
    - Others
  - By Treatment:
    - Non-steroidal Anti-inflammatory Drugs
    - Antiviral
    - Antibacterial
    - Others
  - By End User:
    - Hospitals & Clinics
    - Academic & Research
    - Others
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Drug Type:
  - By Diagnosis:
    - Physical Examination
    - Microbial Culture
    - Biopsy
    - Others
  - By Treatment:
    - Non-steroidal Anti-inflammatory Drugs
    - Antiviral
    - Antibacterial
    - Others
  - By End User:
    - Hospitals & Clinics
    - Academic & Research
    - Others
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Diagnosis:
    - Physical Examination
    - Microbial Culture
    - Biopsy
    - Others
  - By Treatment:
    - Non-steroidal Anti-inflammatory Drugs
    - Antiviral
    - Antibacterial
    - Others
  - By End User:
    - Hospitals & Clinics
    - Academic & Research
    - Others
  - By Country:
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Diagnosis:
    - Physical Examination
    - Microbial Culture
    - Biopsy
    - Others
  - By Treatment:
    - Non-steroidal Anti-inflammatory Drugs
    - Antiviral
    - Antibacterial
    - Others
  - By End User:
    - Hospitals & Clinics
    - Academic & Research
    - Others
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Diagnosis:
    - Physical Examination
    - Microbial Culture
    - Biopsy
    - Others
  - By Treatment:
    - Non-steroidal Anti-inflammatory Drugs
    - Antiviral
    - Antibacterial
    - Others
  - By End User:
    - Hospitals & Clinics
    - Academic & Research
    - Others
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Pfizer Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Highlights
  - Market Strategies
- Taj Pharmaceutical limited.
- Ciron pharma
- Johnson & Johnson
- GlaxoSmithKline PLC
- Merck & CO., Inc.
- Novartis AG
- Hoffman La Roche AG
- Eli Lily and Company
- AstraZeneca Plc.

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Diagnosis
  - Market Snippet, By Treatment
  - Market Snippet, By End User
  - Market Snippet, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
Global Chronic Gingivostomatitis Treatment Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Market Scenario
- Impact of COVID-19 Market on the Chronic Gingivostomatitis Treatment Products
Global Chronic Gingivostomatitis Treatment Market, By Diagnosis, 2016 – 2027, (US$ Mn)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Physical Examination
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Microbial Culture
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Biopsy
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Global Chronic Gingivostomatitis Treatment Market, By Treatment, 2016 – 2027, (US$ Mn)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Non-steroidal Anti-inflammatory Drugs
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Antiviral
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Antibacterial
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Global Chronic Gingivostomatitis Treatment Market, By End User, 2016 – 2027, (US$ Mn)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Hospitals & Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Academic & Research
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
Global Chronic Gingivostomatitis Treatment Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
  - Market Share Analysis, By Region, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
  - Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
    - S.
    - Canada
- Latin America
  - Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Diagnosis, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Treatment, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
  - Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
    - South Africa
    - Central Africa
    - North Africa
Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Taj Pharmaceutical limited
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Ciron pharma
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Johnson & Johnson
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - GlaxoSmithKline PLC
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Merck & CO., Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Novartis AG
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Hoffman La Roche AG
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Eli Lily and Company
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - AstraZeneca Plc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
- Analyst Views
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 35 market data tables and 30 figures on "Chronic Gingivostomatitis Treatment Market” - Global forecast to 2027

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

CHRONIC GINGIVOSTOMATITIS TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2020 to 2027)

Table of Contents

Research Objectives and Assumptions

Market Purview

Market Dynamics, Regulations, and Trends Analysis

Global Chronic Gingivostomatitis Treatment Market – Impact of Coronavirus (COVID-19) Pandemic

Global Chronic Gingivostomatitis Treatment Market, By Diagnosis, 2016 – 2027, (US$ Mn)

Global Chronic Gingivostomatitis Treatment Market, By Treatment, 2016 – 2027, (US$ Mn)

Global Chronic Gingivostomatitis Treatment Market, By End User, 2016 – 2027, (US$ Mn)

Global Chronic Gingivostomatitis Treatment Market, By Region, 2016 – 2027, (US$ Mn)

Competitive Landscape

Section

EXISTING CLIENTELE

Sales Office (U.S.) :

Menu

Reader Club

Help

Connect With Us :

Secure Payment By :